| Files | Size | Format | View |
|---|---|---|---|
| 1486027.PDF | 1.597Mb | application/pdf |
|
| dc.contributor.advisor | Wilson, Lon J. | dc.creator | Berger, Christopher Scott |
|---|---|
| dc.date.accessioned | 2011-07-25T02:07:09Z |
| dc.date.available | 2011-07-25T02:07:09Z |
| dc.date.issued | 2010 |
| dc.identifier.uri | http://hdl.handle.net/1911/62174 |
| dc.description.abstract | For the first time, C60-monoclonal antibody (mAb) immunoconjugates have been determined to internalize into target cells using water-soluble Gd3+-ion-filled fullerenes (Gd C60(OH) x). Separate conjugations of Gd C60(OH)x with the antibody ZME-018 and a murine antibody mixture (MuIgG) took place in a 1:5 mAb:Gd 60 ratio. Quanitative analysis of the immunoconjugates was established using inductively-coupled plasma mass spectrometry (ICP-MS) and UV-Vis spectrometry (Gd C60+C60). Enzyme-linked immunosorbent assays (ELISA) show little change in the specific binding of the ZME-018 once conjugated. Each immunoconjugate was exposed to two cancer cell lines, A375m (a ZME-018-specific line), and T24, a bladder carcinoma line. Internalization of the immunoconjugate was measured at various timepoints, after which the cells were harvested and digested with 25% HClO3 for Gd3+ analysis by ICP-MS. ICP-MS results show immunoconjugate internalization peaked in the first hour of exposure of the cells with a large dropoff occuring in the subsequent hour. These are the first results demonstrating the practicality of a cancer therapy based on Fullerene Immunotherapy (FIT). |
| dc.format.mimetype | application/pdf |
| dc.language.iso | eng | dc.subject | Chemistry, General Chemistry, Inorganic |
| dc.title | Gadolinium at carbon 60-(ZME-018) immunoconjugate targeting of A375 |
| dc.type.genre | Thesis |
| dc.type.material | Text |
| thesis.degree.discipline | Chemistry |
| thesis.degree.grantor | Rice University |
| thesis.degree.level | Masters |
| thesis.degree.name | Master of Arts |
| dc.identifier.citation | Berger, Christopher Scott. "Gadolinium at carbon 60-(ZME-018) immunoconjugate targeting of A375." Masters Thesis, Rice University, ETD http://hdl.handle.net/1911/62174. |